Gloucester Pharmaceuticals' Series B Round

Gloucester Pharmaceuticals raised a round of funding on October 22, 2004.

Gloucester Pharmaceuticals is developing a late-stage clinical compound for T-cell lymphomas and other malignancies.…

Articles about Gloucester Pharmaceuticals' Series B Round: